Hollings Headlines // April 2019
Hollings Remembered
Hollings leaves important legacy at cancer center and beyond

 Describing Senator Ernest “Fritz” Hollings’ tireless efforts to ensure that South Carolinians had access to high-quality health care, MUSC leaders paused to reflect on the significance of that legacy. Hollings Cancer Center physician, Dr. Gerard Silvestri says, “His legacy is that there is no one more deserving of a namesake for a building and center than Sen. Hollings.Others can donate money to have their name put on the building, whereas Hollings built that center from the ground up, brick by brick.”

Clinical Highlight
Volunteer shows cancer patients and caregivers how to tap into healing powers of art

Local artist Beth Melton-Seabrook will be spending Tuesday mornings at Hollings Cancer Center making a mess with cancer patients and their caregivers – all for the sake of art. She’s thrilled to be doing that as a volunteer offering free, art infusion workshops. Read how to join in the fun. 

Research Highlights
Treating cancer patients who smoke may cost extra $3.4B each year

JAMA Network Open reports that smoking after a cancer diagnosis is associated with additional costs of cancer treatment. Hollings researcher, Dr. Graham Warren , says the study establishes a model to estimate the economic burden of smoking on cancer treatment.

Researcher receives funding to harness power of imaging

Dr. Thierry Pécot, a researcher at Hollings, was one of 17 recipients of the Chan Zuckerberg Initiative award for imaging scientists. Pécot says the $1.1 million, five-year grant will support his current research project to enable biologists to apply deep learning tools to their images.

Centers design strategies for including more minorities in clinical trials

Not one size fits all, and that is evident in the recruitment of minorities into clinical trials, says Dr. Marvella Ford. Ford was part of a study to provide recommendations on how minority populations can best be engaged in clinical trials.

The story of GARP: A potential target for cancer immunotherapy

In an article published online in Cancer Research, Hollings Cancer Center researchers reveal for the first time how the cell surface receptor GARP plays a role in T regulatory cell function and migration to the gut.


Sign-up for Hollings Horizons magazine.

86 Jonathan Lucas Street, Charleston, SC 29425 | Privacy Policy
Connect With Us